EEF2K antibody (AA 162-719) (FITC)
Quick Overview for EEF2K antibody (AA 162-719) (FITC) (ABIN7988583)
Target
See all EEF2K AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 162-719
-
Purpose
- Anti-EEF2K Antibody FITC Conjugated
-
Cross-Reactivity (Details)
- No cross-reactivity with other proteins.
-
Purification
- Immunogen affinity purified.
-
Immunogen
- E.coli-derived human EEF2K recombinant protein (Position: K162-A719).
-
Isotype
- IgG
-
-
-
-
Application Notes
- Flow Cytometry, Optimal dilutions should be determined by end users.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Expiry Date
- 12 months
-
-
- EEF2K (Eukaryotic Elongation Factor-2 Kinase (EEF2K))
-
Alternative Name
- EEF2K
-
Background
-
Background: Eukaryotic elongation factor-2 kinase (eEF-2 kinase or eEF-2K), also known as calmodulin-dependent protein kinase III (CAMKIII) and calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase, is an enzyme that in humans is encoded by the EEF2K gene. This gene encodes a highly conserved protein kinase in the calmodulin-mediated signaling pathway that links activation of cell surface receptors to cell division. This kinase is involved in the regulation of protein synthesis. It phosphorylates eukaryotic elongation factor 2 (EEF2) and thus inhibits the EEF2 function. The activity of this kinase is increased in many cancers and may be a valid target for anti-cancer treatment.
Gene Full Name: eukaryotic elongation factor 2 kinase
-
Gene ID
- 29904
-
UniProt
- O00418
-
Pathways
- AMPK Signaling
Target
-